LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 332 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 2.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $596,000 | +57.3% | 4,544 | +82.6% | 0.05% | +68.8% |
Q1 2021 | $379,000 | -81.4% | 2,488 | -86.1% | 0.03% | -59.5% |
Q2 2019 | $2,042,000 | -7.1% | 17,892 | +10.4% | 0.08% | -30.1% |
Q4 2018 | $2,198,000 | +36.1% | 16,200 | +107.7% | 0.11% | +242.4% |
Q2 2018 | $1,615,000 | -73.8% | 7,800 | -79.1% | 0.03% | -69.2% |
Q1 2018 | $6,160,000 | +118.4% | 37,300 | +81.1% | 0.11% | +154.8% |
Q4 2017 | $2,820,000 | -19.7% | 20,600 | -20.2% | 0.04% | +5.0% |
Q3 2017 | $3,512,000 | -36.0% | 25,800 | -42.9% | 0.04% | -51.8% |
Q2 2017 | $5,487,000 | +144.7% | 45,200 | +140.4% | 0.08% | -21.0% |
Q2 2016 | $2,242,000 | +37.8% | 18,800 | +23.7% | 0.10% | +32.9% |
Q1 2016 | $1,627,000 | +257.6% | 15,200 | +261.9% | 0.08% | +182.1% |
Q4 2015 | $455,000 | -63.1% | 4,200 | -70.8% | 0.03% | -69.9% |
Q3 2015 | $1,233,000 | +166.9% | 14,400 | +140.0% | 0.09% | +111.4% |
Q1 2015 | $462,000 | – | 6,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |